New clinical trial studies the addition of immunotherapy to chemotherapy for patients with biliary tract carcinoma

Jun 22, 2017

New clinical trial studies immunotherapy and chemotherapy combination for patients with bile duct cancer for whom surgery is not an option.  Learn more...

New clinical trial studies therapy for Von Hippel-Lindau disease-associated kidney cancer

Jun 19, 2017

A new study aims to test targeted therapy in patients with Von Hippel-Lindau (VHL) disease-associated clear cell renal cell carcinoma.  Learn more...

New clinical trial studies a new drug for mesothelin-positive lung cancer

Jun 15, 2017

A new phase II clinical trial is testing whether a new drug, anetumab ravtansine, can shrink tumors in mesothelin-positive lung cancer and is now recruiting patients.  Learn more...

New combination therapy clinical trial opens for patients with metastatic or unresectable solid tumors

Jun 13, 2017

A clinical trial of a new drug combination is now open for patients with metastatic or unresectable solid tumors. Learn more...

New clinical trial studies the immunotherapy drug pembrolizumab in patients with medullary thyroid cancer

Jun 9, 2017

A new clinical trial studies how the immunotherapy drug pembrolizumab affects patients whose medullary thyroid cancer (MTC) has returned or spread to other areas of the body. Learn more...

Clinical trial explores new glioblastoma treatment regimen

May 22, 2017

On average, a patient with glioblastoma lives for only about a year after diagnosis. In a new clinical trial, CCR researchers will test whether a combination of a vaccine made from the patient’s tumor with another immunotherapy treatment can increase survival rates. Read more...

 

Kristy and her daugher Jane

A Conversation with Kristy and Jane

May 17, 2017

Jane has been coming to the NIH Clinical Center for treatment for neurofibromatosis type 1 (NF1) since she was three years old. She is currently enrolled in a trial that tests Selumetinib, a MEK inhibitor, and her tumor is now 30.7 percent smaller than when she first started this trial three years ago. Her diagnosis has changed the lives of her family but has also given them new passions and perseverance. Read more...

Clinical trial studies new therapy in children and adults with neurofibromatosis-related GIST

May 15, 2017

A new clinical trial studies how treatment with a protein kinase inhibitor effects NF1-related GIST in children and young adults. Learn more...

Clinical trial shows safety and effectiveness of new combination immunotherapy for advanced liver cancer

May 8, 2017

A recently completed phase I clinical trial at the NIH Clinical Center in Bethesda, Maryland, demonstrates that a combination of two immunotherapy drugs to target hepatocellular carcinoma (HCC) was well-tolerated and shrunk tumors in a larger percentage of patients than the standard monotherapy.  Read more...

New clinical trial studies two-part treatment for patients with gastric cancer

May 1, 2017

A new clinical trial is open to test a two-part treatment for stomach cancer that has spread to the peritoneum.
Learn more...

Pages